HuGE Literature Finder
Records 1-30
|
Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
The Kaohsiung journal of medical sciences 2019 Jan 35 (1): 39-48. Wang Lei, Wang Le-Le, Shang Di, Yin Sheng-Jie, Sun Li-Li, Wang Xiao-Ying, Ji Hong- |
|
Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer.
Chinese medical journal 2018 Aug 131 (16): 1904-1908. Dong Jie, Wang Xu, Yu Yu, Yan Xu, Cui Jiu-W |
|
Interaction Between Environmental Risk Factors and Catechol-O-Methyltransferase (COMT) and X-Ray Repair Cross-Complementing Protein 1 (XRCC1) Gene Polymorphisms in Risk of Lung Cancer Among Non-Smoking Chinese Women: A Case-Control Study.
Medical science monitor : international medical journal of experimental and clinical research 2018 Aug 24 5689-5697. Pan Jian-Liang, Gao Jin, Hou Jian-Hua, Hu De-Zhong, Li L |
|
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 90-96. Liao Wei-Yu, Ho Chao-Chi, Tsai Tzu-Hsiu, Chen Kuan-Yu, Shih Jin-Yuan, Yu Chong-J |
|
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
The pharmacogenomics journal 2018 Apr . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Valdivia-Bautista Javier, Faus-Dáder María José, Calleja-Hernández Miguel Áng |
|
Interactive potential of genetic polymorphism in Xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians.
Mutation research 2018 Feb 826 15-24. Bhardwaj Apurva, Bahl Charu, Sharma Siddharth, Singh Navneet, Behera Digamb |
|
Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Nov 39 (11): 1010428317729270. Tasnim Tasnova, Al-Mamun Mir Md Abdullah, Nahid Noor Ahmed, Islam Md Reazul, Apu Mohd Nazmul Hasan, Bushra Most Umme, Rabbi Sikder Nahidul Islam, Nahar Zabun, Chowdhury Jakir Ahmed, Ahmed Maizbha Uddin, Islam Mohammad Safiqul, Hasnat Ab |
|
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.
Pathology, research and practice 2017 Nov . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Calleja-Hernández Miguel Ángel, Faus-Dáder María Jo |
|
Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.
BMC cancer 2017 Jul 17 (1): 501. Li Dan-Juan, Xiao Do |
|
Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.
Scientific reports 2017 Jul 7 (1): 5593. Tan Li-Ming, Qiu Cheng-Feng, Zhu Tao, Jin Yuan-Xiang, Li Xi, Yin Ji-Ye, Zhang Wei, Zhou Hong-Hao, Liu Zhao-Qi |
|
Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
Medical oncology (Northwood, London, England) 2017 Apr 34 (4): 64. Singh Amrita, Singh Navneet, Behera Digambar, Sharma Siddhar |
|
Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Journal of cellular biochemistry 2017 12 118 (12): 4782-4791. Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H |
|
Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
Genetics and molecular research : GMR 2016 Dec 15 (4): . Liu H F, Liu J S, Deng J H, Wu R |
|
Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.
Genetics and molecular research : GMR 2016 Nov 15 (4): . Liu H X, Li J, Ye B |
|
Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population.
DNA repair 2016 Sep . Singh Amrita, Singh Navneet, Behera Digambar, Sharma Siddhar |
|
The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Cancer medicine 2016 Jul . Wang Suhan, Wang Jianzhong, Bai Yansen, Wang Qing, Liu Li, Zhang Kai, Hong Xiaohua, Deng Qifei, Zhang Xiaomin, He Meian, Wu Tangchun, Xu Ping, Guo Hu |
|
Analyzing the association between XRCC1 c.1804C>A genetic variant and lung cancer susceptibility in the Chinese population.
Genetics and molecular research : GMR 2016 Jun 15 (2): . Jin J J, Wang H Q, Kuang H P, Kang B B, Liu Y H, Wang |
|
GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer.
Genetics and molecular research : GMR 2016 Jun 15 (2): . Bu L, Zhang L B, Mao X, Wang |
|
Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis.
Oncotarget 2016 May . Chen Juan, Wang Zhan, Zou Ting, Cui Jiajia, Yin Jiye, Zheng Wei, Jiang Wuzhong, Zhou Honghao, Liu Zhaoqi |
|
Interaction of the CYP1A1 gene polymorphism and smoking in non-small cell lung cancer susceptibility.
Genetics and molecular research : GMR 2016 14 (4): 19411-7. Xie Y Q, Chen J M, Liu |
|
Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.
Pharmacological research 2016 09 111 877-884. Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Faus-Dáder María José, Calleja-Hernández Miguel Ÿng |
|
Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Sep 17 (9): 720-6. Deng J-H, Deng J, Shi D-H, Ouyang X-N, Niu P |
|
The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Jul . Powrózek T, Mlak R, Krawczyk P, Homa I, Ciesielka M, Kozio? P, Prendecka M, Milanowski J, Ma?ecka-Massalska |
|
Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun 36 (6): 4279-85. Geredeli Caglayan, Artac Mehmet, Yildirim Selman, Inal Ali, Dede Isa, Guler Tunc, Boruban Melih Cem, Koral Lokman, Karaagac Mustafa, Zamani Ayse Gul, Altinok Tamer, Aribas Olgun, Bozcuk Hakan, Demirkazik Ahm |
|
XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 May 36 (5): 3745-50. Zhu Dao-Qi, Zou Qiong, Hu Chun-Hong, Su Jia-Li, Zhou Guang-Hua, Liu Pi |
|
ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Cancer investigation 2015 Apr 33 (4): 107-13. Kalikaki Aristea, Voutsina Alexandra, Koutsopoulos Anastasios, Papadaki Chara, Sfakianaki Maria, Yachnakis Emmanouel, Xyrafas Alexandros, Kotsakis Athanasios, Agelaki Sofia, Souglakos John, Mavroudis Dimitrios, Georgoulias Vassil |
|
The influence of XRCC1 genetic variants on lung cancer susceptibility in Chinese Han population.
Gene 2015 Feb 556 (2): 127-31. Wang Yingyi, Ni Jianjiao, Sun Zhao, Chen Shuchang, Jiao Yuchen, Bai Chunm |
|
Association between polymorphisms in the XRCC1 gene and the risk of non-small cell lung cancer.
Genetics and molecular research : GMR 2015 14 (4): 12888-93. Han J C, Zhang Y J, Li X |
|
Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
International journal of clinical and experimental pathology 2015 8 (4): 4113-9. Han Bateer, Guo Zhanlin, Ma Ying, Kang Shirong, Wang Yufei, Wei Qiyou, Wu |
|
Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer.
Genetics and molecular research : GMR 2015 14 (3): 10331-7. Liu J Y, Liu Q M, Li L |
|
Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer.
International journal of clinical and experimental pathology 2015 8 (4): 4171-6. Kang Shirong, Ma Ying, Liu Caixia, Cao Chunli, Hanbateer , Qi Jiafeng, Li Jiwei, Wu |
|
Polymorphisms of DNA repair genes and lung cancer in chromium exposure.
Advances in experimental medicine and biology 2015 833 1-8. Sarlinova M, Majerova L, Matakova T, Musak L, Slovakova P, Skere?ová M, Kavcová E, Halašová |
|
Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
Scientific reports 2015 5 16482. Yuan Zhengrong, Li Jiao, Hu Ruiqi, Jiao Yang, Han Yingying, Weng Qia |
|
Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
International journal of clinical and experimental pathology 2015 8 (11): 14909-16. Zhao Ruigang, Chen Ga |
|
Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (2): 495-500. Yang Hai-Yan, Yang Si-Yu, Shao Fu-Ye, Wang Hai-Yu, Wang Ya-Do |
|
XRCC1 rs25487 polymorphism is associated with lung cancer risk in epidemiologically susceptible Chinese people.
Genetics and molecular research : GMR 2015 14 (4): 15530-8. Wang X, Ma K W, Zhao Y G, Wang G J, Li |
|
Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
International journal of cancer. Journal international du cancer 2014 Dec 135 (11): 2687-96. Peng Yu, Li Zheng, Zhang Shiheng, Xiong Yanli, Cun Yanping, Qian Chengyuan, Li Mengxia, Ren Tao, Xia Lei, Cheng Yi, Wang Do |
|
Polymorphism of DNA repair gene xrcc1 and lung cancer risk.
Cell biochemistry and biophysics 2014 Dec 70 (3): 1881-6. Wang Hong, Liu Zhan |
|
Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
The clinical respiratory journal 2014 Oct . Du Yong, He Yanchao, Mei Zhoufang, Qian Ling, Shi Jindong, Jie Zhij |
|
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
Cancer letters 2014 Oct 353 (2): 160-6. Sullivan Ivana, Salazar Juliana, Majem Margarita, Pallarés Cinta, Del Río Elisabeth, Páez David, Baiget Montserrat, Barnadas Agus |
|
Lung cancer risk and genetic variants in East Asians: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5173-9. Zhang Qu, Jin Hong, Wang Lin, Xin BoBo, Zhang Jie, Zhou Yi, Sheng Sito |
|
No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5629-35. Zhang Jing, Zeng Xian-Tao, Lei Jun-Rong, Tang Yi-Jun, Yang Jio |
|
The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5389-93. Wang Li, Chen Zhenhong, Wang Yajuan, Chang De, Su Longxiang, Guo Yinghua, Liu Changti |
|
DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.
Gene 2014 Apr 538 (2): 361-5. Li Wusheng, Li Kai, Zhao Li, Zou Huaw |
|
Genetic factors in individual radiation sensitivity.
DNA repair 2014 Apr 16 54-65. Hornhardt Sabine, Rößler Ute, Sauter Wiebke, Rosenberger Albert, Illig Thomas, Bickeböller Heike, Wichmann Hans-Erich, Gomolka Mar |
|
Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 1739-43. Wang Ruotian, Zhang Yi, Zhang Jian, Zhi Xiu |
|
X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 411-8. Wang Ji-Ying, Cai Yo |
|
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk.
Genetics and molecular research : GMR 2014 13 (4): 10223-30. Sun B B, Wu J Z, Li Y G, Ma L |
|
Association of the XRCC1 c.1178G>A genetic polymorphism with lung cancer risk in Chinese.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (9): 4095-9. Wang Lei, Lin Yong, Qi Cong-Cong, Sheng Bao-Wei, Fu Ti |
|
Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
PloS one 2014 9 (6): e99843. Du Yan, Su Tong, Zhao Lijun, Tan Xiaojie, Chang Wenjun, Zhang Hongwei, Cao Guangw |
|
Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
Genetics and molecular research : GMR 2014 13 (3): 7617-25. Jin Z Y, Zhao X T, Zhang L N, Wang Y, Yue W T, Xu S |
|
Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (5): 1993-9. Saikia Bhaskar Jyoti, Phukan Rup Kumar, Sharma Santanu Kumar, Sekhon Gaganpreet Singh, Mahanta Jagadi |
|
Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy.
Genetics and molecular research : GMR 2014 13 (1): 228-36. Zhang L, Ma W, Li Y, Wu J, Shi G |
|
Polymorphisms in the XRCC1 gene are associated with treatment response to platinum chemotherapy in advanced non-small cell lung cancer patients based on meta-analysis.
Genetics and molecular research : GMR 2014 13 (2): 3772-86. Li L, Wan C, Wen F |
|
Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer.
Genetics and molecular research : GMR 2014 13 (2): 3100-7. Liu D, Wu J, Shi G Y, Zhou H F, Yu |
|
Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3681-5. Li Yi, Huang Yi, Cao Yu-Shu, Zeng Jia, Tong Wan-Ning, Xu Shi-Lin, Zhuo An-Sh |
|
Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
Molecular carcinogenesis 2013 Dec 52 (12): 923-31. Liu Li, Wu Jing, Zhong Rong, Wu Chen, Zou Li, Yang Beifang, Chen Wei, Zhu Beibei, Duan Shengyu, Yu Dianke, Tan Wen, Nie Shaofa, Lin Dongxin, Miao Xiaopi |
|
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2013 Nov 82 (2): 330-9. Lee Shin Yup, Kang Hyo-Gyoung, Yoo Seung Soo, Kang Ye Rim, Choi Yi Young, Lee Won Kee, Choi Jin Eun, Jeon Hyo-Sung, Shin Kyung Min, Oh In Jae, Kim Kyu Sik, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Kim Young Chul, Park Jae Yo |
|
Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2843-8. Ouyang Fang-dan, Yang Fu-lan, Chen Han-chun, Khan Md Asaduzzaman, Huang Feng-mao, Wan Xin-xing, Xu Ai-hua, Huang Xing, Zhou Mei-juan, Fang Qian, Zhang Dian-zhe |
|
X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2611-5. Wu Tao, Xu Yun-hua, Ye Xiao-l |
|
XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2989-94. Guo Qin-xiang, Yang Wei-hua, Zhai Jin-fang, Han Fu-cai, Wang Chun-y |
|
DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
Molecular biology reports 2013 Sep 40 (9): 5261-73. Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, Kavcova E, Jakusova V, Janickova M, Drgova A, Berzinec P, Halasova |
|
Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2013 May 71 (5): 1287-95. Zhao Wan, Hu Lingmin, Xu Jiali, Shen Hongbing, Hu Zhibin, Ma Hongxia, Shu Yongqian, Shao Yongfeng, Yin Yongm |
|
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.
British journal of cancer 2013 Apr 108 (8): 1695-703. Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, Grossi F, Recchia F, Zanelli F, Fontanini G, Naldi N, Campanini N, Azzoni C, Bordi C, Ardizzoni A, |
|
Analysis of Single Nucleotide Polymorphisms and Radiation Sensitivity of the Lung Assessed With an Objective Radiologic Endpoint.
Clinical lung cancer 2013 Jan . Kelsey CR, Jackson IL, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB |
|
Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
International journal of radiation oncology, biology, physics 2013 Jan 85 (1): 251-7. Tucker Susan L, Li Minghuan, Xu Ting, Gomez Daniel, Yuan Xianglin, Yu Jinming, Liu Zhensheng, Yin Ming, Guan Xiaoxiang, Wang Li-E, Wei Qingyi, Mohan Radhe, Vinogradskiy Yevgeniy, Martel Mary, Liao Zhongxi |
|
[Association of the polymorphism of dna repair genes with chromosomal aberrations in lung cancer patients].
Molekuliarnaia genetika, mikrobiologiia i virusologiia 2013 (4): 3-6. Bakanova M L, Minina V I, Savchenko Ia A, Timofeeva A A, Dudkina O A, Titov V A, Verzhbitskaia N |
|
Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
PloS one 2013 8 (8): e68457. Huang Guohua, Cai Shaoxi, Wang Wei, Zhang Qing, Liu Aih |
|
No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (9): 5171-4. Sun Yan, Zhang Yong-Jun, Kong Xiang-Mi |
|
The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (9): 5275-9. Natukula Kirmani, Jamil Kaiser, Pingali Usha Rani, Attili Venkata Satya Suresh, Madireddy Umamaheshwar Rao Nai |
|
The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese.
PloS one 2013 8 (2): e56213. Guo Shujie, Li Xiaobo, Gao Min, Li Yuqiong, Song Bei, Niu Wenqu |
|
Prognostic Significance of GSTP1, XRCC1 and XRCC3 Polymorphisms in Non-small Cell Lung Cancer Patients.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (9): 9. Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY |
|
XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies.
Journal of Zhejiang University. Science. B 2012 Nov 13 (11): 875-83. Chen Jian, Zhao Qing-wei, Shi Gen-ming, Wang Lin-r |
|
Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.
Molecular carcinogenesis 2012 Oct 51 Suppl 1 E11-20. Buch Shama C, Diergaarde Brenda, Nukui Tomoko, Day Roger S, Siegfried Jill M, Romkes Marjorie, Weissfeld Joel |
|
Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
International journal of cancer. Journal international du cancer 2012 Oct 131 (7): E1100-8. Butkiewicz Dorota, Drosik Anna, Suwi?ski Rafa?, Krze?niak Ma?gorzata, Rusin Marek, Kosarewicz Agata, Rachtan Jadwiga, Matuszczyk Iwona, Gawkowska-Suwi?ska Marze |
|
XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.
Molecular biology reports 2012 Oct 39 (10): 9535-47. Dai Liping, Duan Fujiao, Wang Peng, Song Chunhua, Wang Kaijuan, Zhang Jianyi |
|
DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy.
Medical oncology (Northwood, London, England) 2012 Sep 29 (3): 1622-8. Li Dairong, Zhou Qi, Liu Yu, Yang Yanqing, Li Qiyi |
|
Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
Molecular carcinogenesis 2012 Jul 51 (7): 546-52. Dong Jing, Hu Zhibin, Shu Yongqian, Pan Shiyang, Chen Wenping, Wang Yi, Hu Lingmin, Jiang Yue, Dai Juncheng, Ma Hongxia, Jin Guangfu, Shen Hongbi |
|
Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jul 18 (14): 3972-81. Wu Junjie, Liu Jie, Zhou Yuhao, Ying Jun, Zou Houdong, Guo Shicheng, Wang Lei, Zhao Naiqing, Hu Jianjun, Lu Daru, Jin Li, Li Qiang, Wang Jiu-C |
|
Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Jun 7 (6): 973-81. Liao Wei-Yu, Shih Jin-Yuan, Chang Gee-Chen, Cheng Yu-Kai, Yang James Chih-Hsin, Chen Yuh-Min, Yu Chong-J |
|
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study.
Cancer 2012 May 118 (9): 2466-75. Joerger Markus, Burgers Sjaak A, Baas Paul, Smit Egbert F, Haitjema Tjeerd J, Bard Martin P L, Doodeman Valerie D, Smits Paul H M, Vincent Andrew, Huitema Alwin D R, Beijnen Jos H, Schellens Jan H |
|
[Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
Wei sheng yan jiu = Journal of hygiene research 2012 Mar 41 (2): 251-6. Wang Na, Wu Yongjun, Zhou Xiaolei, Wu Yimi |
|
Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012 Mar 14 (3): 207-13. Chen Xiaoxia, Sun Hui, Ren Shengxiang, Kim Curran Vikramsingh, Zhang Ling, Zhou Songwen, Zhang Jie, Zhou Caic |
|
[The polymorphisms of XRCC1 gene and susceptibility to pulmonary cancer].
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 2012 Jan 30 (1): 41-4. Wang Na, Wu Yong-Jun, Zhou Xiao-Lei, Wu Yi-Mi |
|
Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
Cancer 2012 Jan 118 (2): 528-35. Yin Ming, Liao Zhongxing, Liu Zhensheng, Wang Li-E, O'Reilly Michael, Gomez Daniel, Li Minghuan, Komaki Ritsuko, Wei Qing |
|
Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
BMC cancer 2012 12 (1): 71. Cui Zhigang, Yin Zhihua, Li Xuelian, Wu Wei, Guan Peng, Zhou Baos |
|
XRCC3 gene polymorphism is associated with survival in Japanese lung cancer patients.
International journal of molecular sciences 2012 13 (12): 16658-67. Osawa Kayo, Nakarai Chiaki, Uchino Kazuya, Yoshimura Masahiro, Tsubota Noriaki, Takahashi Juro, Kido Yoshia |
|
[Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2011 Dec 14 (12): 912-7. Xu Chong'an, Wang Xiaojie, Zhang Ye, Li L |
|
An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.
Molecular biology reports 2011 Nov 38 (8): 5231-41. Butkiewicz Dorota, Rusin Marek, Sikora Bo?ena, Lach Antonina, Chor??y Mieczys? |
|
Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
International journal of radiation oncology, biology, physics 2011 Nov 81 (3): e67-73. Yin Ming, Liao Zhongxing, Liu Zhensheng, Wang Li-E, Gomez Daniel, Komaki Ritsuko, Wei Qing |
|
Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Lung cancer (Amsterdam, Netherlands) 2011 Aug 73 (2): 138-46. Qian Biyun, Zhang Huan, Zhang Lina, Zhou Xiaoying, Yu Herbert, Chen Kex |
|
Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 110-5. Liu Li, Yuan Peng, Wu Chen, Zhang Xiaomin, Wang Feng, Guo Huan, Zhong Rong, Xu Yihua, Wu Jing, Yu Dianke, Wu Tangchun, Zhang Xuemei, Nie Shaofa, Miao Xiaoping, Lin Dongx |
|
Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 25-31. Cho Sukki, Kim Min Jung, Choi Yi Young, Yoo Seung Soo, Lee Won Kee, Lee Eun Jin, Jang Eun Jeong, Bae Eun Young, Jin Guang, Jeon Hyo-Sung, Lee Shin Yup, Cha Sung-Ick, Park Tae In, Kim Chang Ho, Park Jae Yo |
|
DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma.
Cancer 2011 Jul 117 (14): 3201-8. Han Ji-Youn, Yoon Kyong-Ah, Park Jae Hee, Lee Young Joo, Lee Geon Kook, Han Jong Hee, Yoon Sung Jin, Yun Tak, Kim Heung Tae, Lee Jin S |
|
Association of XRCC3 and XPD751 SNP with response to platinum-based chemotherapy in advanced NSCLC patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e18045. Chen X, Zhou C, Sun H, Ren S, Zhang L, Zhou |
|
EGFR FASTnet: The Italian network for epidermal growth factor receptors (EGFR) mutation analysis in non-small cell lung cancer (NSCLC).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e18026. Normanno N, Pinto C, Taddei G L, Mari E, Troncone G, Graziano P, Mottolese M, Ludovini V, Zupo S, De Maglio G, Russo A, Larocca L M, Di Maio M, Gambacorta M, Nappi O, Viale G, Ardizzoni A, Crinò L, Perrone F, Marchetti |
|
Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population.
Archives of medical research 2011 Apr 42 (3): 226-34. Li Zheng, Guan Wei, Li Meng-xia, Zhong Zhao-yang, Qian Cheng-yuan, Yang Xue-qin, Liao Ling, Li Zeng-peng, Wang Do |
|
Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients.
Swiss medical weekly 2011 141 w13275. Zhou Fei, Yu Zhuang, Jiang Tao, Lv Hongying, Yao Ruyong, Liang J |
|
Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751.
Asian Pacific journal of cancer prevention : APJCP 2011 12 (3): 739-42. Li Yan, Huang Xin-En, Jin Guang-Fu, Shen Hong-Bin, Xu L |
|
Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells.
Carcinogenesis 2010 Dec 31 (12): 2091-6. Lee Mi-Sun, Su Li, Mark Eugene J, Wain John C, Christiani David |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: